CeriBell, Inc. Common Stock (CBLL)

• Market cap: $672M
• 1 day: -2.45%
• 5 days: -7.04%
• 1 month: -23.88%
• 3 months: -27.53%
• 6 months: -25.04%
• Year to date: -27.53%
• 1 year: -25.04%
• 5 years: -25.04%
• 10 years: -25.04%
• Sector: Healthcare
• Industry: Electromedical & Electrotherapeutic Apparatus

About: CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Employees: 281

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

64.46% more ownership

Funds ownership: 0% [Q3] → 64.46% (+64.46%) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $33 76% upside
• Avg. target: $33 76% upside
• High target: $33 76% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Canaccord Genuity William Plovanic 46% 1-year accuracy 22 / 48 met price target

76% upside $33

Buy Maintained

26 Feb 2025